semaglutide pediatric obesity

Novo Nordisk says semaglutide cut obesity rates in young children in trial — Photo by Gustavo Fring on Pexels

Experts Agree Semaglutide Cuts Pediatric Obesity by 30%

Yes, recent trial data show semaglutide reduces pediatric obesity by about 30 percent, offering a new tool for clinicians. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Semaglutide Pediatric Obesity: The Emerging Standard